Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationLymphoma, Large B-Cell, DiffuseStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTransplantation ConditioningTransplantation, HomologousHematopoietic Stem Cell MobilizationMelphalanCyclophosphamideTreatment OutcomeMultiple MyelomaLymphoma, Non-HodgkinHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Lymphoma, B-CellMyeloablative AgonistsBlood Component RemovalRemission InductionGraft vs Host DiseaseVincristineEtoposideSalvage TherapyBusulfanBone Marrow TransplantationThiotepaRecurrenceGraft SurvivalHematopoietic Stem CellsCarmustineDisease-Free SurvivalHodgkin DiseaseStem CellsAntineoplastic Agents, AlkylatingDoxorubicinCytarabineSurvival RateRetrospective StudiesPrednisoneIfosfamideAmyloidosisAntineoplastic AgentsSurvival AnalysisAntibodies, Monoclonal, Murine-DerivedWhole-Body IrradiationLymphomaCord Blood Stem Cell TransplantationLymphoma, FollicularTransplantation ChimeraPrognosisCytophagocytosisTime FactorsHematopoiesisBone Marrow PurgingTissue DonorsDexamethasoneNeoplasmsFollow-Up StudiesFatal OutcomeCarboplatinLeukemia, Myeloid, AcuteProto-Oncogene Proteins c-bcl-6Lymphoma, T-CellHistocompatibilityImmunosuppressive AgentsHistocompatibility TestingInfectionLiver TransplantationProspective StudiesGerminal CenterPlatelet CountVidarabineLeukemiaTransplantation, IsogeneicFeasibility StudiesMyelodysplastic SyndromesPOEMS SyndromeMesenchymal Stem Cell TransplantationGraft vs Leukemia EffectImmunophenotypingRecombinant ProteinsChemotherapy, AdjuvantLymphoma, T-Cell, PeripheralBlood Cell CountNeoplasm, ResidualCytomegalovirus InfectionsLymphoma, Mantle-CellBreast NeoplasmsBone MarrowCell TransplantationChemotherapy-Induced Febrile NeutropeniaLymphoproliferative DisordersBlood CellsB-LymphocytesBlood Transfusion, AutologousPrecursor Cell Lymphoblastic Leukemia-Lymphoma